GET THE APP

Photophobia and Migraine Outcome during Treatment with Galca | 100768

Revista de neurología y neurofisiología

ISSN - 2155-9562

Abstracto

Photophobia and Migraine Outcome during Treatment with Galcanezumab

Catherine Lapp

The Calcitonin Gene-Related Peptide (CGRP), which affects both migraine pain and accompanying symptoms including photophobia, is crucial to the physiology of migraines. The current study sought to determine if monoclonal antibodies that target CGRP are effective in lowering ictal photophobia as well as headache and migraine frequency and disability.

Descargo de responsabilidad: Este resumen fue traducido utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.